Scilex Holding (SCLX) Net Cash Flow (2020 - 2026)
Scilex Holding (SCLX) posted quarterly Net Cash Flow of -$1.1 million for Q1 2026, down 144.42% year-over-year from $2.5 million in Q1 2025, and down 123.3% quarter-over-quarter from $4.8 million in Q4 2025.
Scilex Holding (SCLX) Net Cash Flow (2020 - 2026) Analysis & Trends
Scilex Holding's Net Cash Flow history runs 7 years deep, the most recent figure standing at -$1.1 million for Q1 2026.
- In Q1 2026, Net Cash Flow fell 144.42% year-over-year to -$1.1 million; the TTM figure through Mar 2026 stood at -$1.2 million (down 140.05% YoY), while the FY2025 annual figure was $2.4 million, up 267.4% from the prior year.
- Net Cash Flow for Q1 2026 stood at -$1.1 million, down from $4.8 million in the prior quarter.
- The five-year high for Net Cash Flow was $30.1 million in Q2 2023, with the low at -$33.1 million in Q3 2023.
- The 5-year median for Net Cash Flow is -$1.1 million (2026), against an average of $14705.9.
- Peak annual rise in Net Cash Flow reached 9813.22% in 2022, while the deepest fall reached 11419.18% in 2022.
- Scilex Holding's Net Cash Flow stood at -$299000.0 in 2022, then jumped by 1019.4% to $2.7 million in 2023, then sank by 276.21% to -$4.8 million in 2024, then jumped by 199.5% to $4.8 million in 2025, then slumped by 123.3% to -$1.1 million in 2026.
- Business Quant data shows SCLX's Net Cash Flow at -$1.1 million in Q1 2026, $4.8 million in Q4 2025, and -$3.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | -1.27 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | -2.82 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 1.53 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 757.00 Mn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | -6.80 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 1.95 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | -4.43 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | -722.00 Mn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 2.68 Bn |
| 10 | Scilex Holding | 39.22 Mn | -73.57 Mn | 3.97 Mn | -2.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.12 Mn |
| Mar 31, 2026 | -1.12 Mn |
| Dec 31, 2025 | 4.82 Mn |
| Dec 31, 2025 | 4.82 Mn |
| Sep 30, 2025 | -3.21 Mn |
| Sep 30, 2025 | -3.21 Mn |
| Jun 30, 2025 | -1.70 Mn |
| Jun 30, 2025 | -1.70 Mn |
| Mar 31, 2025 | 2.53 Mn |
| Mar 31, 2025 | 2.53 Mn |
| Dec 31, 2024 | -4.84 Mn |
| Dec 31, 2024 | -4.84 Mn |
| Sep 30, 2024 | -1.55 Mn |
| Sep 30, 2024 | -1.55 Mn |
| Jun 30, 2024 | 6.89 Mn |
| Jun 30, 2024 | 6.89 Mn |
| Mar 31, 2024 | -1.96 Mn |
| Mar 31, 2024 | -1.96 Mn |
| Dec 31, 2023 | 2.75 Mn |
| Dec 31, 2023 | 2.75 Mn |